Mode
Text Size
Log in / Sign up
N/A N=55 Randomized Single-blind Prevention

Esophageal Cooling for AF Ablation

Atrial Fibrillation

Enrolled (actual)
55
Serious AEs
0.0%
Results posted
Dec 2021
Primary outcome: Primary: Number and Percentage of Participants With Esophageal Thermal Injury — 8; 5; 13 Participants — p=>.05

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Esophageal Cooling (Device); Control (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
University of Pennsylvania
Primary completion
Mar 2020

Outcome Measures

OutcomeResultp-value
PRIMARY
Number and Percentage of Participants With Esophageal Thermal Injury
8; 5; 13 >.05
PRIMARY
Number and Percentage of Participants With Esophageal Injury Based on Severity
1; 2; 6; 0; 1; 3
SECONDARY
Posterior Wall Ablation Parameters: Temperature
25.0; 25.7 0.11
SECONDARY
Posterior Wall Ablation Parameters
10; 10 0.73
SECONDARY
Occurrence of Acute PV Reconnection
6; 1 0.10

Summary

The purpose of this study is to determine if esophageal cooling using the Attune Medical Esophageal Heat Transfer Device (EnsoETM) limits the number or seriousness of injury to the esophagus during atrial fibrillation ablation procedures. The EnsoETM is an FDA cleared device used for temperature management, but is not routinely used during atrial fibrillation ablation procedures.

Eligibility Criteria

Inclusion Criteria

  • Patients above the age of 18 years old.
  • Patients with the diagnosis of atrial fibrillation undergoing clinically indicated de-novo AF ablation procedure.
  • Patients must be able to understand and critically review the informed consent form.

Exclusion Criteria

  • Patients whom are unable to provide informed consent.
  • Patients with contraindication to EGD.
  • History of prior AF ablation procedures.
  • Significant co-morbidities that preclude standard ablation procedure.
  • Patient is ineligible for EnsoETM placement due to:
  • Known esophageal deformity or evidence of esophageal trauma (for example history of esophagectomy, previous swallowing disorders, achalasia).
  • Known ingestion of acidic or caustic poisons within the prior 24 hours.
  • Patients with <40 kg of body mass.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03691571). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search